Table 6.
Parameters of zeolites for the removal of selected NSAIDs (diclofenac, ibuprofen, and naproxen) and selected antibiotics (erythromycin, sulfamethoxazole, tetracycline, and trimethoprim).
| Adsorbate | Framework Type of Zeolite (Si/Al Ratio) | Dose (g L−1) |
Contact Time (h) | T (°C) |
Concentrations | pH | Reference |
|---|---|---|---|---|---|---|---|
| Sodium diclofenac |
zeolite ZSM-5 hierarchical ZSM-5 |
0.05 | 1.0 | 29.85 | 10–1000 µM | - | [157] |
| Sodium diclofenac |
natural Jordanian zeolite (intermediate silica) | 2.0 | 1.2 | - | 10.0; 20.0; 40.0; 50.0 × 104 µg L−1 |
6.0 | [159] |
| Sodium diclofenac |
TMOR18 (50% w/w TiO2) TMOR240 (50% w/w TiO2) |
0.7 | - | - | 100 μg L−1 | - | [162] |
| Sodium diclofenac |
MNCZ | 0.05 | - | 30 ± 1 | 100 µg L−1 | 2.0–9.0 | [158] |
| Erythromycin | zeolite Y | - | - | - | 0–5 × 103 µg L−1 | - | [98] |
| Erythromycin | Zeocem a.s. 200 μm Zeocem a.s. 0.5–1 mm Zeocem a.s. 1–2.5 mm |
0.05 | 0.5 | - | 0.016 µg L−1
0.037 µg L−1 |
pH = 6.85 pH = 7.01 |
[164] |
| Ibuprofen | natural Jordanian zeolite (Intermediate silica) | 1.0 | 1.2 | - | 10.0; 20.0; 40.0; 50.0 × 104 µg L−1 | 2.0 | [159] |
| Ibuprofen Naproxen | MNCZ | 0.05 | - | 30 ± 1 | 100 µg L−1 | 2.0–9.0 | [158] |
| Naproxen | ZSM5 MOR200 |
0.05 | - | - | 2 µg L−1 | 6.0 | [99] |
| Sulfametoksazole | FAU-1 FAU-2 |
0.50 | 2.0 | - | 1.0 × 105 μg L−1 | 6.5 | [62] |
| Sulfamethoxazole | zeolite Y MOR ZSM5 |
0.50 | 24.0 | 21 21 65 |
30 µM | - | [165] |
| Sulphamethoxazole | TMOR18 (50% w/w TiO2) TMOR240 (50% w/w TiO2) |
0.70 | - | - | 100 μg L−1 | - | [162] |
| Sulphamethoxazole | zeolite Y | 0.50 | 1.0 | - | 50 µM | 5–8 | [166] |